MARKET

PODD

PODD

Insulet
NASDAQ

Real-time Quotes | Nasdaq Last Sale

175.13
+9.46
+5.71%
Opening 15:46 04/08 EDT
OPEN
168.30
PREV CLOSE
165.67
HIGH
175.72
LOW
163.87
VOLUME
204.32K
TURNOVER
--
52 WEEK HIGH
219.85
52 WEEK LOW
80.43
MARKET CAP
11.01B
P/E (TTM)
943.08
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 19 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PODD stock price target is 187.00 with a high estimate of 206.00 and a low estimate of 125.00.

EPS

PODD News

More
  • Why Diabetes Stock Insulet Fell 13% in March
  • MotleyFool.com · 1d ago
  • Insulet to Announce First Quarter 2020 Financial Results on May 7, 2020
  • Business Wire · 2d ago
  • A Good Entry Point In DexCom
  • Seeking Alpha - Article · 04/01 18:00
  • Mizuho sees 86% upside in Sarepta in premarket analyst action
  • Seeking Alpha - Article · 03/31 11:18

Industry

Medical Equipment, Supplies & Distribution
+5.17%
Healthcare Equipment & Supplies
+4.30%

Hot Stocks

Symbol
Price
%Change

About PODD

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). The Omnipod System features two discreet devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. The Omnipod System is a discreet two part design, the Omnipod device (Pod) and the PDM that eliminates the need for the external tubing required with conventional pumps. The Pod is a self-adhesive device that the patient fills with insulin and wears directly on the body.
More

Webull offers kinds of Insulet Corporation stock information, including NASDAQ:PODD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PODD stock news, and many more online research tools to help you make informed decisions.